Maxcyte:
global cell therapy company providing proprietary non-viral cell engineering technology for the next generation of cell-based therapies including gene editing and immuno-oncology. MaxCyte has a blue chip client base, 120+ issued licences, and potential $800m+ pre-commercial milestone potential from existing licenses. In addition, MaxCyte is seeking independent financing for CARMA (mRNA-based CAR platform) to establish it as a separate therapeutics company and allow MaxCyte to focus on its core cell-engineering business.
Sector/Industry:
Healthcare/Medical Diagnostics & Research
Characteristics:
Based in...
US - South Atlantic
Clinical Stage
Phase l or ll, Pre-Clinical Stage
Listing
Europe, Public
Market Cap
<100MM
Therapeutic Modalities
Cell Therapy, Gene editing, Gene Therapy
Website:
Address:
22 Firstfield Road
Suite 110
Gaithersburg, MD 20878
United States
Suite 110
Gaithersburg, MD 20878
United States
Company Participants at Solebury Trout Virtual Global Healthcare Conference Series
- Douglas Doerfler, CEO
More info:
My account:
Top 10 Holders of MaxCyte, Inc.
| Institution | OS (%) | Position | Mkt Val ($MM) | Source | Filing Date |
|---|---|---|---|---|---|
| Casdin Capital LLC | 21.97 | 11,281,334 | 52.00 | Stakes | 8/27/20 |
| River & Mercantile Asset Management LLP | 14.79 | 7,597,587 | 35.02 | Stakes | 8/11/20 |
| Canaccord Genuity Wealth Ltd. | 8.05 | 4,134,578 | 19.06 | Funds | 4/30/20 |
| Unicorn Asset Management Ltd. | 5.88 | 3,017,857 | 13.91 | Funds | 8/31/20 |
| BlackRock Investment Management (UK) Ltd. | 3.66 | 2,799,279 | 12.90 | Stakes | 1/21/20 |
| Legal & General Investment Management Ltd. | 3.35 | 2,562,752 | 11.81 | Stakes | 1/21/20 |
| Chelverton Asset Management Ltd. | 4.67 | 2,400,000 | 11.06 | Funds | 6/30/20 |
| Amati Global Investors Ltd. | 3.33 | 1,709,728 | 7.88 | Funds | 6/30/20 |
| Amati Global Investors Ltd. (Venture Capital) | 1.25 | 957,860 | 4.41 | Funds | 1/31/20 |
| Octopus Investments Ltd. | 1.43 | 901,660 | 4.16 | Funds | 8/31/20 |
Top 10 Holders of MaxCyte, Inc. TEMP
| Institution | OS (%) | Position | Mkt Val ($MM) | Source | Filing Date |
|---|---|---|---|---|---|
| Octopus Investments Ltd. | 5.00 | 298,063 | 1.37 | Funds | 2/29/20 |
| BlackRock Investment Management (UK) Ltd. | 3.68 | 219,041 | 1.01 | Stakes | 1/21/20 |
Ownership data is sourced through FactSet.
Stock Market Data
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by
QuoteMedia.
Terms of Use.